Cut out the (estrogen) middleman

Dec 08, 2009

Estrogen seems to act like a middleman in its positive effect on the brain, raising the possibility that future drugs may bypass the carcinogenic hormone altogether while reaping its benefits.

A split-personality chemical, is thought to protect neural circuits and boost learning and memory, while at the same time increasing when taken in high doses.

In a study published online today in the (PNAS), neuroscientists at USC and the Western University of Health Sciences show that estrogen sometimes acts through another chemical.

Their experiments on mice verified that the hormone stimulates parts of the dedicated to learning and memory.

"We show very clearly that it does activate the same machinery that is activated during learning and memory," said Michel Baudry, professor of neurobiology at the USC College of Letters, Arts and Sciences.

But the researchers also found that estrogen acts through calpain, a protein considered crucial to learning and memory since a seminal paper in 1984 by Baudry and Gary Lynch of the University of California, Irvine on the biochemistry of memory.

Baudry is senior co-author on the PNAS study, which implies that the hormonal description of estrogen needs revisiting.

Estrogen acting through calpain does not work as a slowly diffusing hormone, Baudry said, but as a neurotransmitter with a more powerful and nearly immediate effect on the brain.

He compared estrogen to adrenalin, a substance that acts like a hormone in most of the body but as a neurotransmitter in the brain.

"It's not a hormonal effect. It's a synaptic modulator. It completely changes the way we look at estrogen in the brain," Baudry said.

That change may lead to better drugs against Alzheimer's and other neurodegenerative diseases, according to USC graduate student and lead author Sohila Zadran.

"Estrogen is critically involved in and ," she said, and the PNAS study shows that its effects "critically involve calpain."

In the future, drug developers may choose to target calpain directly, possibly avoiding the risks associated with therapy.

Such a strategy would not have been possible if Baudry's group had not clarified estrogen's mechanism of action.

"If you don't understand the mechanism, it really makes it difficult to go after a problem," Zadran said.

Source: University of Southern California (news : web)

Explore further: A new cause of mental disease?

add to favorites email to friend print save as pdf

Related Stories

Decoy pill saves brain cells

Jan 31, 2007

Tricking a key enzyme can soothe over-excited receptors in the brain, say neuroscientists, calling this a possible strategy against stroke, Alzheimer's and other neurodegenerative diseases.

Improved estrogen reception may sharpen fuzzy memory

Jul 29, 2008

Estrogen treatments may sharpen mental performance in women with certain medical conditions, but University of Florida researchers suggest that recharging a naturally occurring estrogen receptor in the brain may also clear ...

Recommended for you

A new cause of mental disease?

1 hour ago

Astrocytes, the cells that make the background of the brain and support neurons, might be behind mental disorders such as depression and schizophrenia, according to new research by a Portuguese team from ...

Molecular basis of age-related memory loss explained

Jul 22, 2014

From telephone numbers to foreign vocabulary, our brains hold a seemingly endless supply of information. However, as we are getting older, our ability to learn and remember new things declines. A team of ...

The neurochemistry of addiction

Jul 22, 2014

We've all heard the term "addictive personality," and many of us know individuals who are consistently more likely to take the extra drink or pill that puts them over the edge. But the specific balance of ...

Study examines blood markers, survival in patients with ALS

Jul 21, 2014

The blood biomarkers serum albumin and creatinine appear to be associated with survival in patients with amyotrophic lateral sclerosis (ALS) and may help define prognosis in patients after they are diagnosed with the fatal ...

User comments : 0